Entities
LogoName Σ Employees
InSiliBio InSiliBio

We use innovating solutions to test molecules through original bioinformatic methods. Our proposed methods are fully eth InSiliBio is a revolutionary contract research organization (CRO). We use innovating solutions to test molecules through original bioinformatic methods. Within the perspective of developing novel products and formulations, cosmetic, pharmaceutic and food companies undertake long research (up to several years), with expensive investments. These experiments often provide only fragmented information. These trials are sometimes being conducted on living organisms (animals, human cell etc. ), which are increasingly questioned from an ethical standpoint. Our proposed methods are fully ethical, fast, reliable and cost-effective. Our …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

14 8 8 7
Hybrigenics Services Hybrigenics Services

Expert in target deconvolution for drugs, protein-protein interactions and single-domain antibodies Who else knows your drug or protein better than you? Who else knows protein interactions better than us? Hybrigenics Services is a complete solution provider of cutting-edge technologies dedicated to the study of protein interactions and target identification for drugs. We are also proud to now offer a unique, proprietary nanobody selection service. We help researchers: - Understand proteins'​ functions through the elucidation of their interactions - Characterize precisely a known interaction (map critical domains or amino-acids...) - Identify the targets of small molecules of therapeutic interest - Predict …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

3 1 2 32
coIMMUNE, Inc. coIMMUNE, Inc.

coIMMUNE is a privately held, clinical stage immune-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies. Our allogeneic CAR-CIK technology platform for liquid and solid tumors is a novel CAR therapy that promises enhanced efficacy with greatly reduced toxicity.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

5 2 3 19
Access to Medicine Foundation Access to Medicine Foundation

Moving pharmaceutical companies to expand access to their products in low- & middle-income countries The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. We seek to transform the healthcare ecosystem by motivating and mobilising companies to expand access to their essential healthcare products in low- and middle-income countries. Over the past two decades, we have demonstrated the power of data, collaboration and persuasion to trigger action by the pharmaceutical industry and scale up access to products. Our tried-and-tested approach involves defining the actions that healthcare companies should take, analysing what companies are actually doing, and …

Type: SMB Activities: healthtech biotech civictech deeptech Technologies: Synthetic Biology

6 3 3 52
Bridge2Food Bridge2Food

Bringing together the world’s leading and most innovative plant-based food and alternative protein creators. Bridge2Food brings together the world’s leading and most innovative plant-based food and alternative protein creators. Our mission is to achieve global food sustainability for future generations to come, without compromising on food experience. We connect professionals across the value chain who share this goal, and together we will build a better food world. Community, Plant-Based Foods, Proteins, Active Nutrition, EcoSystems, Summits + Expo, Conferences, Courses, Academy, and alternative proteins

Type: SMB Activities: foodtech Technologies: Synthetic Biology

5 0 4 20
Theraclion Theraclion

Creators of extracorporeal robotic treatment platforms Theraclion is a French MedTech company committed to developing a non-invasive alternative to surgery through the innovative use of focused ultrasound. High Intensity Focused Ultrasound (HIFU) does not require incisions nor an operating room, leaves no scars, and allows patients an immediate return to their daily activities. Echotherapy, as the HIFU treatment method is called, concentrates therapeutic ultrasounds to an internal focal point from outside of the body. Theraclion has developed two CE-marked robotic platforms delivering echotherapy: SONOVEIN® for varicose veins and ECHOPULSE® for breast fibroadenoma and thyroid nodules. Each representing the potential to …

Type: SMB Activities: healthtech deeptech Technologies: Robotics Synthetic Biology

2 0 2 38
PHAXIAM Therapeutics PHAXIAM Therapeutics

Creating a global leader in extended phage therapies PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. PHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

11 3 6 90
Innate Pharma Innate Pharma

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

18 7 11 202
SafeHeal SafeHeal

Reshaping RecoveryTM Established in 2015 and based in France, SafeHealTM is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented by French surgeon Charam Khosrovani to eliminate the need for diverting ostomies in patients undergoing colectomy. medical device

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

2 1 0 18
BIOGARAN BIOGARAN

[Automatic translation follows] The box that takes care of you. French drug laboratory 🇫🇷 Biogaran was founded in 1996, to specifically respond to the development of a new, still little-known market: generic medicines. Offering patients quality medicines with recognized effectiveness whose patent has fallen into the public domain then required a new type of know-how that traditional laboratories did not possess. Our know-how is available through different ranges: from minor everyday ailments with the Biogaran Conseil® range, to more serious pathologies with prescription medications. Whatever the pathology, patient health is at the heart of Biogaran's concerns and the same rigor …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

8 2 4 506
Laboratoires Théa Laboratoires Théa

Théa, Let's Open Our Eyes Laboratoires Théa is a pharmaceutical industry specialized in ophthalmology. The group is the leader in several therapeutic classes as well as in the field of preservative-free eye drops. Laboratoires Théa is an innovative company dedicated to developing high-quality products that support ophthalmic care and eye health across more than 70 countries. Ophthalmology, Pharmaceuticals, Medical Devices, Eye care, Eye Health, and Preservative-free

Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

8 6 2 755
OZ Biosciences OZ Biosciences

OZ Biosciences creates, develops and commercializes life sciences reagents specialized in transfection and transduction OZ Biosciences is a product development company that creates, develops and commercializes delivery systems of bioactive materials (DNA, siRNA, proteins, antibodies...), intended for the worldwide scientific community and pharmaceutical industries. Our mission is to assist scientists to accelerate the rhythm of discoveries by offering them technologically advanced tools such as transfection reagents and other life science research products. Principal innovations are based on propietary technologies such as Magnetofection (magnetic-assisted transfection or infection), Magneto-Biolistic, transfection reagents, transduction tools, mRNA and lipids-based delivery systems (LNP). Specialized and expert …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

1 1 0 19
genOway genOway

Together, we science better Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research. Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

4 2 1 105
EDAP TMS EDAP TMS

Bringing New Horizons to Therapy EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and …

Type: SMB Activities: healthtech deeptech manufacturing Technologies: Robotics Synthetic Biology

2 1 1 202
OMEICOS Therapeutics GmbH OMEICOS Therapeutics GmbH

Developing 1st-in-class therapeutics based on the profound understanding of omega-3 fatty acid metabolism OMEICOS Therapeutics has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids that have the potential to treat mitochondrial dysfunction, inflammatory, cardiovascular and other diseases. Epoxyeicosanoids activate cell type-specific endogenous pathways that promote organ and tissue protection. OMEICOS’ small molecules are orally available and show improved biological activity and pharmacokinetic properties compared to their natural counterparts. The currently active PMD-OPTION Phase 2a clinical study is evaluating OMEICOS’ lead development program OMT-28 in patients with Primary Mitochondrial Disease. Drug development, Cardiovascular Research, and Mitochondrial …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 0 2 9
RetroBrain R&D GmbH RetroBrain R&D GmbH

Spielend körperlich und geistig aktiv sein Retrobrain is researching and developing novel serious gaming approaches to solve challenges in medical care and therapy with a particular focus on the elderly, Alzheimer's disease as well as motion/gesture based control schemes utilizing Kinect and other motion-sensing equipment. More generally, we are working with researchers and teams around the world to explore how serious therapeutic games can best be used to improve mental and physical health and to alleviate or prevent illness. We are currently implementing our award-wining proof-of-concept with technology partners including Microsoft Germany, research partners at the Humboldt University of Berlin, …

Type: Startup Activities: healthtech silvertech Games Technologies: Synthetic Biology

1 1 1 19
Instituto de Biología Molecular y Celular de Plantas, IBMCP (UPV - CSIC) Instituto de Biología Molecular y Celular de Plantas, IBMCP (UPV - CSIC)

[Automatic translation follows] Discovering from green - Scientific research aimed at obtaining plants with better productivity, fruit quality or with properties of high added value (of interest to the consumer, farmers and the agri-food industry) and more resistant to stress, as well as less dependent on chemical treatments, in order to contribute to less aggressive agriculture with the environment. - Advanced services in Genomics, Proteomics, Metabolomics, Bioinformatics, Microscopy, Plant Hormone Quantification, DNA Sequencing and Gene Expression Analysis. - Training of research personnel. Biotechnology, Molecular Biology, Genomics, Proteomics, Bioinformatics, Metabolomics, Systems Biology, and Synthetic Biology

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

3 0 0 177
AMSBIO AMSBIO

AMSBIO is a global supplier of research products and custom services for biological and pharmaceutical research Founded in 1987, AMS Biotechnology (AMSBIO) is recognised today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology products and services for research and development in the medical, nutrition, cosmetics and energy industries. The AMSBIO range includes specialist antibodies, peptides and recombinant proteins. In addition the company is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as experts in cell …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

1 0 1 32
DiaMonTech AG DiaMonTech AG

Say goodbye to finger pricking! Awarded for “most innovative German startup” from German business magazine Bilanz, DiaMonTech has developed a medical device that non-invasively measures your blood glucose without finger pricking, a drop of blood, or a test strip. Simply relax your fingertip on the sensor, wait 5 to 15 seconds, and your blood glucose level will be displayed. Our patented technology works with an invisible infrared light beam that looks into your skin and counts glucose molecules. Diabetes is a global challenge. More than 400 million people worldwide suffer from the disease. Our goal is to make checking your …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

0 0 0 28
Naturae Naturae

[Automatic translation follows] Europe's first biofactory aimed at obtaining natural and healthy products, based on biotechnology. Naturae © is a set of ingredients that can be added to all types of foods and drinks and that, among other beneficial effects for our health, safely and naturally activate the immune system, enhance cholesterol control and improve cardiovascular circulation. Naturae © is obtained from its own and registered strains of natural mushrooms, such as shiitake or yeast. It is completely free of genetically modified organisms (GMOs) and its extraction is carried out naturally, using patented methods, without the addition of synthetic substances. …

Type: Startup Activities: foodtech Technologies: Bio sourced materials Synthetic Biology

0 0 0 33
Dewpoint Therapeutics Dewpoint Therapeutics

Translating condensate biology into medicine. Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has multiple programs across an ambitious pipeline spanning oncology, neurodegeneration, cardiopulmonary, and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Merck, and Pfizer. Dewpoint scientists work in Boston, Dresden and Frankfurt to translate condensate biology into breakthrough treatments for diseases previously considered untreatable. biomolecular condensates, oncology, neurodegeneration, cardiopulmonary, virology, insulin resistance, …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3 0 2 141
H4B Boston H4B Boston

The Premier Commercialization and Marketing Partner for Orphan Drugs and Rare Disease Markets Worldwide H4B Boston is an agency dedicated to rare disease and rare oncology. We work with companies from early-mid clinical development through launch and end of life cycle to develop commercial strategies, meaningfully engage with the patient/clinician community, and ensure that their rare disease therapies reach the right patients. Our practice areas include: · Early commercial strategy support with a focus on patient perspective and launch readiness · Omnichannel physician marketing · Omnichannel patient/caregiver marketing · Unbranded and disease state education programs (HCP/patient) · Advocacy strategy/programming · …

Type: Startup Activities: healthtech martech Technologies: Synthetic Biology

3 1 0 34
Xkelet Xkelet

We develop Medical Device Software for professionals to produce personalized products using AI to automatize the process We want to change the current immobilization methods such as plaster and current orthotic systems, to solve the problems that come from these immobilization systems. The immobilizations are printed with 3D printing technology and suitable for accurate measurements of the patient's anatomy. With Xkelet, the patient can shower and dry without problems, no longer scratching due to scaling of the skin, in case the injury includes a wound already well derived by the fracture itself as an operative process, the patient and the …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

4 0 3 18
Apprentice.io Apprentice.io

Getting medicine to patients faster using the Tempo Manufacturing Cloud, a single platform for end-to-end production. Apprentice helps life science manufacturers get therapeutics to patients faster by providing one platform to turn molecules into medicine. Our Tempo Manufacturing Cloud accelerates the end-to-end drug product lifecycle by connecting together distributed teams and sites, helping them execute better on the shop floor, and optimizing their operations through enterprise-wide visibility. From preclinical benchtop to large-scale commercial manufacturing, Tempo keeps your global teams connected, empowered, and in sync. cell & gene therapy, life sciences, batch records, pre-clinical manufacturing, clinical manufacturing, commercial manufacturing, procedure execution, …

Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

3 0 1 118
Causeway Sensors Limited Causeway Sensors Limited

Causeway Sensors uses nanotechnology to provide better candidate selection during drug development. The company spun-out after years of high-impact research at Queen's University Belfast. Our unique nanochip platform brings real-time, label-free kinetic analysis to areas of biotherapeutic production where such data cannot currently be collected. More data at critical points of production helps pharma companies ensure that only the best drug candidates progress to clinical trials. The platform can be incorporated into a multitude of form factors, ranging from a high-throughput screening instrument to an in-line cell culture monitoring tool. Biosensing, Protein - Protein Interactions, Binding Kinetics, Biotechnology, Biotherapeutics, Antibody …

Type: Startup Activities: biotech deeptech Technologies: Data Analytics Synthetic Biology

1 0 0 15
MSD Italia MSD Italia

[Automatic translation follows] We have always invented for one great purpose: Life We have always invented for one great purpose: Life MSD, known in the United States and Canada as Merck & Co., Inc., with headquarters in Kenilworth, (New Jersey, USA), is an American multinational leader in the pharmaceutical sector. For over 65 years in Italy and 130 in the world, we have revolutionized therapeutic paradigms for dozens of pathologies through the discovery of over 200 innovative molecules. Our mission is to discover, develop and make available innovative products and services that save and improve the lives of Patients around …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

10 0 5 505
WCG WCG

We improve lives by accelerating research, together. WCG is a true partner to research sponsors, CROs, sites and participants in navigating the clinical research journey. The pioneer of independent ethical review, now the industry gold standard, WCG’s 55-year legacy of independent review solutions serves as the foundation on which we continually build to accelerate and improve the clinical research journey. We lead the way by reimagining processes, optimizing quality and safety, strengthening productivity, and pioneering new solutions that leverage data and technology to accelerate research and impact global health. WCG liberates study stakeholders from the constraints that risk trial efficacy …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 0 1 1,243
FairJourney Biologics FairJourney Biologics

FairJourney Biologics, your end-to-end antibody partner At FairJourney Biologics, cutting-edge science meets unparalleled expertise in antibody discovery and development. As your leading end-to-end solutions partner for antibody solutions, we are committed to revolutionizing your research and fast-tracking the success of your programs. With top-tier technologies and a team of seasoned researchers, we take pride in delivering high-quality, reliable antibodies tailored to meet your unique demands. Drawing upon over a decade of extensive expertise in antibody discovery and development, we have achieved remarkable results, with at least 14 antibodies having advanced to clinical stages as a direct outcome of these endeavours. …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 0 279
Dragonfly Therapeutics, Inc. Dragonfly Therapeutics, Inc.

Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas. For more information, email info@dragonflytx.com. immuno-oncology

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3 0 0 116
AVROBIO AVROBIO

Clinical-stage lentiviral gene therapy company, powered by plato®. Our vision: bring personalized gene therapy worldwide Our vision is to bring personalized gene therapy to the world. We target the root cause of genetic disease by introducing a functional copy of the affected gene into patients’ own hematopoietic stem cells (HSCs), with the goal of durably expressing the therapeutic protein throughout the body, including the central nervous system. Our first-in-class pipeline includes clinical programs for Gaucher disease and Hunter syndrome, as well as a preclinical program for Pompe disease. Our proprietary plato® gene therapy platform is scalable for planned global commercialization. …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

3 1 0 40
Skyhawk Therapeutics Skyhawk Therapeutics

We Use Small Molecules To Modify RNA Splicing Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that modify RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted toward cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 1 65
Frequency Therapeutics Frequency Therapeutics

Frequency Therapeutics is pioneering a new category in regenerative medicine. Frequency’s progenitor cell activation platform aims to restore human function by developing therapeutics that activate a person’s innate regenerative potential within the body. The Company’s lead preclinical program is designed to activate oligodendrocyte precursor cells with the goal of driving remyelination and potential functional recovery for individuals living with multiple sclerosis.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 0 1 15
Apollomics Apollomics

We are a biopharmaceutical company committed to the discovery and development of mono- and combination cancer therapies. Apollomics is an innovative biotechnology company committed to the discovery and development of oncology combination therapies. With operations in both the U.S. and China, we believe we are well positioned to unlock synergies by leveraging the strengths of partnerships with other biotechnology companies in the East and the West. Since our founding in 2015, under the leadership of our experienced management team with in-depth knowledge and expertise of the evolving cancer treatment landscape, we have built a pipeline of ten (10) drug candidates …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 1 31
Poseida Therapeutics, Inc. Poseida Therapeutics, Inc.

The Capacity to Cure Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes allogeneic CAR-T cell therapy product candidates for both solid and liquid tumors as well as in vivo gene therapy product candidates that address patient populations with high unmet medical need. The Company's approach to cell and gene therapies is based on its proprietary genetic editing platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVERTM Site-Specific Gene Editing System and nanoparticle and hybrid gene delivery technologies as well as in-house …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 0 2 329
Civica Rx Civica Rx

Serving patients is a privilege that comes with significant responsibilities. Civica Rx was created in late 2018 to secure the supply of important medicines hospitals use every day. As of Q1 2024, we have provided over 155 million units of essential medicines to hospitals, enough to help treat nearly 70 million patients. Recently, we announced we will manufacture and distribute affordable medications for consumers in an outpatient/retail setting, including affordable insulin. Insulin is an exciting project as we are partnering with nearly every corner of the diabetes ecosystem to bring low-cost insulin to people living with diabetes at no more …

Type: Startup Activities: deeptech biotech manufacturing Technologies: Synthetic Biology

1 0 0 160
Abzena Abzena

Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

6 0 0 446
Voyager Therapeutics, Inc. Voyager Therapeutics, Inc.

Breaking through barriers in gene therapy and neurology Voyager Therapeutics (Nasdaq: VYGR) is a biotechnology company dedicated to breaking through barriers in gene therapy and neurology. The potential of both disciplines has been constrained by delivery challenges; Voyager is leveraging cutting-edge expertise in capsid discovery and deep neuropharmacology capabilities to address these constraints. Voyager’s TRACERTM AAV capsid discovery platform has generated novel capsids with high target delivery and blood-brain barrier penetration at low doses, potentially addressing the narrow therapeutic window associated with conventional gene therapy delivery vectors. This platform is fueling alliances with Alexion (AstraZeneca Rare Disease); Novartis Pharma AG; …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3 0 2 193
NovioSense BV NovioSense BV

NovioSense BV is a spin out company from Fraunhofer Gesellschaft and NovioTech BV based in Nijmegen. NovioSense is a wireless platform technology for non-invasive monitoring of disease biomarkers. The first sensor based on the NovioSense technology is a wireless non-invasive glucose sensor. Development is targeted at a clinical prototype for non-invasive continuous monitoring of glucose levels in tear fluid. Medical Devices, Sensor Development, Diabetes, and Medical Technology

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 N/A
Precigen Precigen

Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of gene and cell therapies. Precigen: Advancing Medicine with PrecisionTM Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 115
Sen-Jam Pharmaceutical Sen-Jam Pharmaceutical

We’re changing the way the world treats inflammation and the way the pharma industry treats humanity Join the revolution! We’re changing the way the world treats inflammation and the way the pharma industry treats humanity. Invest today → https://wefunder.com/senjam Sen-Jam's Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph. It's time for a stronger, more resilient world, free of side-effects and filled with living remarkably Inflammation , Wellbeing, and Pain Relief

Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

0 0 0 9
InCarda Therapeutics InCarda Therapeutics

Pioneering inhaled medications for cardiovascular conditions InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF). Cardiovascular, Inhalation therapy, Biotechnology, Pharmaceuticals, Clinical Development, Drug Formulation, Commercialization, Clinical Research, Pre-Clinical Research, and Regulatory Affairs

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 0 0 16
MindMed MindMed

MindMed is a clinical-stage biopharma company developing novel products to treat brain health disorders MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems. MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

3 0 2 89
American Gene™ American Gene™

A cell & #genetherapy company with a #gene delivery platform to develop cures to #cancer #HIV #PKU. In Phase 1 trial for #HIVcure. CEO @JeffreyGalvin.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 N/A
Insmed Incorporated Insmed Incorporated

Insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. The Company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. Headquartered in Bridgewater, NJ, we are a rapidly growing company with offices in seven countries. Biotechnology, Orphan Disease State, Pharmaceuticals, Chronic Lung Infections, and Pulmonary

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

2 0 1 965
Crinetics Pharmaceuticals Crinetics Pharmaceuticals

Discovering drugs for endocrine diseases and endocrine-related tumors. #acromegaly #crinetics #CarcinoidSyndrome This place is about more than a pharmaceutical career. It’s about making a real difference in the lives of patients. That’s why we’re here. That’s why you should maybe think about being here, too. Our mission is to build the leading endocrine company that consistently pioneers new therapeutics to help patients better control their disease and improve their daily lives. Working to accomplish this mission is how we bring our vision to life. For us, that vision is the best possible therapeutics available to all patients with diseases of …

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

0 0 0 278
Thabor Therapeutics Thabor Therapeutics

Develops innovative treatments for mucosal inflammatory diseases Thabor's website

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 8
ABC transfer ABC transfer

Ultraclean Sterile Transfer Solutions For The Global Pharmaceutical Industry ABC Transfer is an industrial designer and manufacturer of secure Rapid Transfer Systems (RTS) for the pharmaceutical industry. It provides the ultimate sterile and particle-free environment for safe drug manufacturing and bioprocessing; ensuring GMP compliance, ultra-cleanliness and enhanced ergonomic safety. Its system consists of future-proof alpha doors, beta containers, single-use bags and other superior quality sterile processing accessories based on 12 patented designs. The ABC Transfer system is the first to satisfy 50 improvement criteria resolving customers’ challenges worldwide. Led by an executive team of pharma transfer solution experts with decades …

Type: Startup Activities: Industry 4.0 manufacturing Technologies: Synthetic Biology

0 0 0 11
Roca Therapeutics Roca Therapeutics

A united team creating an innovative therapy to give a new life / vision to patients First In Class Drugs against diseases favored by hyper-vascularization and immuno-suppressive inflammation Cancer treatment, Eye disease, Angiogenesis, Inflammation, Drug development, and Personalized therapy

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

7 3 0 6
Meccellis Biotech Meccellis Biotech

French manufacturer of biologic implants Meccellis Biotech is a company expert in Tissue and Cell Engineering with a diversified offer for multiple surgical specialties. After 7 years of marketing, Meccellis Biotech is now present in 25 countries. The passion and professionalism of its teams have made of Meccellis Biotech, a reference company for the manufacturing of biomaterials. For any further information you may need regarding our range of biologic implants, please feel free to contact us: contact@meccellis.com - Phone number: +33 (0) 5 17 81 07 63 - THE MECCELLIS BIOTECH TEAM Breast reconstruction: CELLIS Breast, General surgery: CELLIS, and …

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

5 1 2 10
WhiteLab Genomics WhiteLab Genomics

AI/ML for Genomic Therapies We are specialised in AI solutions for advanced therapies such as gene and cell therapies.

Tags: FrenchTech2030 Type: Startup Activities: deeptech IT Services Technologies: A.I. A.I. - Machine Learning Synthetic Biology

36 14 26 38
StarkAge Therapeutics StarkAge Therapeutics

Immunotherapy against senescence StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related diseases, associated with senescent cells accumulation. It builds on its unique disease-specific exosomal / EV technology while harnessing immunotherapy approach, to address very large senescence unmet medical needs.

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

1 1 0 10
Ciloa SAS Ciloa SAS

Inspired by Exosomes CILOA’S CUSTOMIZED EXOSOMES FOR INNOVATIVE THERAPEUTICS Ciloa is the most experienced exosome-based R&D Company dedicated to the development of new high-potential bio-drugs. By overcoming undruggable targets, Ciloa supports your projects to create new therapeutic and new preventive solutions. Ciloa customizes in vivo exosomes to contain i) fully native membrane protein complexes (GPCRs, Kinase Receptors, Ion Channels, Viral Antigens, Transporters...) embedded in their membrane and ii) chosen cargo proteins inside their cytosol. Natural properties of exosomes combined with Ciloa in vivo disruptive technology allow to develop: - VIRUS-FREE candidate THERAPEUTIC VECTORS able to deliver specifically chosen cargos to …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3 3 0 9
POLYGON Therapeutics POLYGON Therapeutics

Innovation. Applied. Bringing life to life. POLYGON Therapeutics aims to address unmet therapeutic needs through innovative breakthrough approaches. Within its first therapeutic development program EMOTION, POLYGON aspires to transform cardiovascular diseases care.

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

12 5 10 9
Vaxxel Vaxxel

The future of vaccines against respiratory infections. Vaxxel develops novel and proprietary live-attenuated vaccines candidate against bronchiolitis and pneumonia and in particular against human Metnapneumovirus and against human Respiratory Virus. Vaxxel is a spin off fom Virpath, the virology and human pathology Laboratory of the University Claude Bernard in Lyon (UCBL), France, and has been founded by Dr. Manuel Rosa-Calatrava Co-Director of Virpath (Lyon), Pr. Guy Boivin of the University of Laval (Quebec), by Denis Cavert, President of Vaxxel. recherche-développement, biotechnologies, santé, and vaccin

Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

6 0 6 11
Ermium Therapeutics Ermium Therapeutics

Controlling auto-immune diseases Ermium Therapeutics is a discovery stage Biotechnology company developping innovative therapies for auto-immune diseases

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 2 0 9
Jalon Therapeutics Jalon Therapeutics

Jalon Therapeutics aims to develop innovative therapies that inactivate yet untargeted vital tumor signaling pathways. Jalon Therapeutics aims to develop innovative therapies that inactivate yet untargeted vital tumor signaling pathways. Our mission is to develop medicines that will transform the lives of people fighting cancer. For that purpose, we leverage our deep understanding of stress-related protein-protein interaction networks that sustain the malignant phenotype while not being necessary for normal cells. This mechanism, defined as “non-oncogene addiction” (NOA), offers potential novel, safer and more effective therapeutic strategies. Jalon Therapeutics is rooted in pioneering fundamental research and clinical investigations from INSERM laboratories …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 5
Brenus Pharma Brenus Pharma

Tumor-antigen focused immunotherapies anticipating tumor plasticity, resistance to treatments and relapses ✔️🟣 Brenus Pharma, french private start-up in biotechnology based in Lyon, develops a platform technology to deliver first-in-class tumor-antigen focused immunotherapy. The STC (Stimulated Tumor Cells) Technology allogeneic platform deliver STC drug product, in 3 major steps: 🟣 Cell Selection to mimic tumor heterogeneity & resistance capacities of the selected indication. 🟣 In vitro induction and overexpression of resistances marker by stimulation with Standard of care and Rx. • 100+ cancer related surface proteins over expressed • Cross-matching human tumoral biopsy databases • Covering 3 categories of targets (Tumor …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

14 4 8 14
LinKinVax LinKinVax

LinKinVax aims at creating a universal, safe, enduring, vaccines platform against multiple pathogens. We are a clinical stage Biotech Spin-off of the Vaccine Research Institute in France with a unique "DC targeting" platform covering infectious desaeses and oncology.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

10 0 10 13
AdipoPharma SAS AdipoPharma SAS

French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and associated comorbidities AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. Our first-in-class candidate - PATAS - is set to enter clinical trials later this year.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

9 3 6 64
BiPER Therapeutics BiPER Therapeutics

First in class small molecules pushing cancer cells to burn out BiPER Therapeutics is developing a first-in-class pipeline of small molecules targeting the global metabolism of cancer. The company’s lead compound, BPR001, is a first-in-class small molecule therapeutic targeting BiP, an oncogenic protein shown to have a critical role in cancer through the modulation of the endoplasmic reticulum stress.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

10 6 9 7
Immusmol Immusmol

Immusmol develops small molecule antibodies for research, diagnostics and therapy. Combining 25 years of experience in antigen design, we offer to target low molecular weight molecules, which are not usually addressed by antibodies, such as amino acid metabolites, lipids, saccharids, toxins, pesticide residues, small molecule drugs, ... Compatible with existing antibody-based technologies, our small molecule antibodies can serve for: > VISUALIZATION: Small molecule antibodies currently represent the only applicable technology for the visualization of small molecules in cells and tissues by IF or IHC. > QUANTIFICATION: Combined with ELISA/EIA technologies, small molecule antibodies enable rapid and robust detection of small …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 1 0 10
INOVOTION INOVOTION

Which molecule will stand out INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to anti-cancer treatment evaluations and early toxicity studies. Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage. This breaking-thought technology, based on chick embryo, provides early analysis of your treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs. It’s rapid Go/No Go decision with multi-cancer screening capacities. This next generation of in vivo efficacy …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

9 4 5 21
Ecrins Therapeutics Ecrins Therapeutics

Ecrins Therapeutics is a biotechnology company which focuses on the discovery and development of novel anti-cancer compounds from the preclinical phase to phase II clinical proof of concept. In addition to the drug discovery, Ecrins Therapeutics provides a range of products and services for the benefit of our customers in biotechnology companies, universities, public research institutions and in the pharmaceutical industry. The mission of the commercial division of Ecrins Therapeutics is to help medical chemists and drug hunters to discover, characterize and advance their lead compounds through the drug development process. Visit http://ecrins-therapeutics-services.com/ for more information. Our research and production …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

2 0 2 1
Ludocare Ludocare

Evidence-based digital therapies that improve adherence and overall health of children with chronic conditions. Created in 2017 in Lyon, Ludocare develops evidence-based digital therapies for the benefit of patients, those around them and healthcare professionals. ✅ Its objective: better control of the disease and stabilization of basic treatment, to improve the quality of life of children with chronic illnesses. 💡The medical purpose of JOE digital therapy is to improve asthma control through better use of inhalation devices and increased compliance with drug treatments, and thus preventively reduce attacks and exacerbations. ➡️ To date, Ludocare is part of a scientific approach …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

15 8 13 7
Orakl Oncology Orakl Oncology

Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology Data Analytics

14 6 11 9
OSE Immunotherapeutics OSE Immunotherapeutics

Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients OSE Immunotherapeutics is an integrated biotech company focused on developing first-in-class assets targeting cancer and inflammatory diseases. A current well-balanced first-in-class clinical pipeline including: • Tedopi® (T-cell specific immunotherapy): Company’s most advanced product; positive results for Ph 3 in NSCLC in secondary resistance after CKI failure. Other sponsored combo Ph 2 trials in solid tumors ongoing. • OSE-279 (anti-PD1) advanced preclinical stage • OSE-127 (humanized mAb antagonist of IL-7R); ongoing Ph 2 in Ulcerative Colitis; ongoing preclinical research in leukemia • VEL-101/FR104 (anti-CD28 mAb) developed in partnership with Veloxis in transplantation; ongoing …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

9 6 2 1
AnyGenes® AnyGenes®

Since more than 10 years, AnyGenes® scientists develop and produce innovative high throughput screening products for signaling pathway analysis. These kits and reagents allow high throughput transcriptomic analysis of a large collection of signaling pathways in many species, biomarkers identification and validation, as well as validation of microarrays results. AnyGenes®, with its innovative & cost effective technologies, products and its proprietary molecular platform, helps scientists to accelerate their projects, publications, and biotech companies for drug development and biomarkers validation. Located in Paris, within Tenon Hospital in the 20th arrondissement, AnyGenes® constitutes a key player in the Biotechnology field. Supported by …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 6
ANAQUANT ANAQUANT

Identify and quantify your Host cell proteins thanks to our HCP profiler solution! #TechnologicalCRO #HCP ANAQUANT provides pharmaceutical and biotech companies with high quality services in detection and quantification of proteins by mass spectrometry, in order to speed up their R&D. Thanks to its unique know-how in control and validation of protein quantification, ANAQUANT is a partner of choice for customized assay development of proteins. Our expertise in performing specific and sensitive assays – from one to several dozens of proteins in a small sample volume – significantly contributes to the success of discovery and validation of biomarkers. Our proprietary …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 1 2 10
kyron.bio kyron.bio

Next generation bioproduction platform Kyron.bio is revolutionising the way we make our therapeutic drugs. Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective. Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved by the pharmaceutical …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

10 3 8 4
Myotact Myotact

Innovation for patient autonomy Myotact is a medical device that detects muscle activity by EMG and translates it into virtual movement with vibrotactile feedback.

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

23 5 22 1
CLEAN BIOLOGICS CLEAN BIOLOGICS

Making it possible CLEAN BIOLOGICS is a CDMO for Viral vectors, Viral vaccines and oncolytic viruses and Biosafety testing for biological products. As well as a CMO for MCB & WCB production. GMP compliance

Type: Startup Activities: deeptech Technologies: Synthetic Biology

13 7 11 11
IMODI Cancer IMODI Cancer

Building a sustainable sector and accelerate the discovery of new treatments tailored to each patient. French consortium to develop new experimental models of cancer in 9 cancer pathologies of interest (Lung, Pancreas, Breast, Liver, Ovary...) 3 major R&D axes: - Developing in vivo models and cell-based assays - Mimicking the human biology by humanizing the tumor microenvironment in mice - Studying the microbiota in cancer patients Oncology, Cancer research, Patient derived Xenograft, Cell lines, Ex vivo assays, Microbiota, Data mining , Translationnal medecine, Humanized mice, Biomarker, Research and Development, In vivo models, Ex vivo models, and Cancer

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 0 N/A
KCAS Bio - Lyon KCAS Bio - Lyon

Science Accelerated KCAS Bio - Lyon (Active Biomarkers) operates as a bioanalytical laboratory based in Lyon, France and headquartered in Olathe, Kansas, USA. We offer comprehensive service solutions for the development of both large and small molecules, with extensive capabilities and expertise in pharmacokinetics, immunogenicity, soluble and cellular biomarker analysis for clinical trials. Operating in state-of-the-art BSL2 facilities, our company is GLP certified and ISO 9001:2015 certified, with a unique track-record in the development, validation, and implementation of analytical methods. Our expert team has supported hundreds of studies in multiple therapeutic areas: oncology, infectious diseases, inflammatory pathologies, and neurodegenerative diseases. …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology Data Analytics

2 1 2 30
LXRepair LXRepair

2013-2023 In a context where the rate of cancer treatment failure is still unacceptably high, our mission is to provide decision aids to oncologists. We believe that profiling is key to predicting treatment toxicity to patients and effectiveness on tumors. Over a decade of research by the French Atomic Energy Commission (CEA) on the impact of radiations on DNA has resulted in a deep understanding of the essential DNA repair mechanisms. More recently, a set of innovative biomarkers was developed that provides a complete functional signature of these mechanisms, the premise to powerful tools for personalized treatment of cancer. http://www.lxrepair.com …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 1 1 3
MAG4HEALTH MAG4HEALTH

Affordable high-end neuroimaging We make and sell brain imaging systems showing neural activity called magnetoencephalographs (MEG). We democratize the use of MEG, using a space technology, to effectively detect brain defects and improve brain cares MEG, medical device, and functional imaging

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

4 3 1 17
AUROBAC THERAPEUTICS AUROBAC THERAPEUTICS

Developing the next generation of precision medicines to fight antimicrobial resistance (AMR) and infectious diseases. AUROBAC THERAPEUTICS is a biopharmaceutical company created in 2022 by three highly renowned life sciences innovation companies, Boehringer Ingelheim, Evotec and bioMérieux, to develop the next generation of precision medicines addressing the medical needs associated with the development of antimicrobial resistance and infectious diseases. The company is building a pipeline of drug candidates for hospitalized patients, associated with rapid diagnostics to identify pathogens and their resistance mechanisms. This 40 million euros-funded joint-venture plans to cover the entire value chain of projects from R&D, including clinical …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3 1 2 14
MEXBRAIN MEXBRAIN

[Automatic translation follows] Therapeutic dialysis devices for metal extraction MexBrain develops medical devices capable of specifically, quickly and controlledly extracting metals. MexBrain has designed an ultrachelating platform: fluids capable of extracting metals associated with dialysis systems. These devices are specific to the targeted metals and have an adjustable extraction capacity. No medication or product circulates directly in the body, limiting side effects. Nanotechnologies, Dialysis, Metals, and Chelation

Type: Startup Activities: nanotech biotech deeptech healthtech Technologies: Synthetic Biology

3 2 1 13
ORPHELIA Pharma ORPHELIA Pharma

Our mission is to develop essential medicines to improve care and support of pediatric orphan diseases ORPHELIA Pharma is a French pharmaceutical company dedicated to the development and marketing of pediatric drugs for oncology and CNS diseases. ORPHELIA’s mission is to significantly improve essential medicines administered to children through the development of efficient, reliable and safe drugs with child-friendly formulations. We focus on developing optimized formulations for the pediatric population of approved drugs as well as obtaining the approval for existing drugs in new pediatric orphan indications. We are also leading R&D projects aiming at developing new drugs for pediatric …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 1 0 10
LabSkin Creations LabSkin Creations

Your Skin Designer LabSkin Creations is a biotechnology company specializing in advanced 3D skin and adipose tissue engineering. By combining innovative cell culture techniques as well as proprietary technologies based on scaffolding biomaterials and 3D bioprinting approaches, LabSkin designs and creates unique and versatile 3D reconstructed models for the performance evaluation of skin and personal care products and their ingredients. tests d'activité et d'efficacité, analyse d'image, Histologie, Immunohistochimie, Biologie cutanée, 3D, Reconstructed skin, and Adipose Tissue

Type: Startup Activities: deeptech Industry 4.0 Technologies: Synthetic Biology

7 6 1 10
Cellenion Cellenion

Experts in single cell isolation technology for sequencing and cell line development applications. Cellenion offers solutions and technologies for controlled cell dispensing with applications in the fields of single-cell isolation and bioprinting : Ability to manipulate single-cell has long been a challenge for the scientific community due to their micrometric size and delicate nature. Cellenion has developed and patented CellenONE, a breakthrough single cell isolation and dispensing technology. CellenONE provides outstanding single cell precision, high throughput, and unmatched recovery. Bioprinting is the process of generating spatially-controlled cell patterns using 3D printing technologies. Cellenion will aim toward both miniaturization and automation …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3 1 2 29
BIOMNIGENE BIOMNIGENE

Molecular biology thought for your needs Biomnigene, a bioanalysis service company, helps prevent potential diseases and to authenticate, trace, secure, validate products and their effects through genetic analysis. Thanks to our expertise, we offer you integrated services for environmental, industrial (pharmaceutical, agro-food, cosmetic) or medical issues such as: - Analysis of the intestinal, skin, vaginal, pulmonary and soil microbiome (16S/ITS metagenomic, shotgun metagenomic, transcriptomic, WGS...). - Identification, quantification and authentication, monitoring of species in a pure sample and in a mixture (microorganisms, viruses, bacteria, meat, fish). - Genotyping - Antibody sequencing and safeguarding of hybridoma lines of special interest; - …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 2 1 6
Exeliom Biosciences Exeliom Biosciences

Crossing the next frontier, to give you a fair chance to fight Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms. Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

9 4 7 7
ANTINEO ANTINEO

Antineo aims to accompany customers in the preclinical development of novel anticancer agents. We provide services and strategic advice for preclinical development, optimal choice of in vitro and in vivo models as well as strategic input on potential indications to target in the therapeutic landscape. Développement préclinique, in vitro, ex vivo, in vivo, Preuve de concept, Expertise scientifique en pharmacologie, and Modèles à façon

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 1 2 11
Kejako Kejako

Keep your Eyes Young Our mission Kejako, in the field of ophthalmology, merge Medtech and Engineering expertise to develop solution for interested presbyopic patients seeking to keep quality of life through the compensation of visual accommodation decay. We address presbyopia with an anti-aging mindset to treat the gradual loss of visual accommodation. Our promise, unlike any other existing surgical solution, is to provide non-invasive (ultra-minimally invasive or a “no-cut”) laser solution to delay the need for reading glasses without compromising the patient’s quality of vision. Our solution will be fully personalized to the patient by using our simulation expertise which …

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

4 2 2 6
NETRI NETRI

INNERVATE. SCREEN. PREDICT. NETRI is a technology enabling company that provides human cell based smart assays for high throughput preclinical data acquisition for the neurological Pharma & Cosmetics industries. We provide organs-on-chip solutions & interoperable in vitro models designed to deeply accelerate drug discovery and preclinical trials by mimicking in vivo neural connectivity. neuroscience, microfluidics, neural network, organ on chip, neurofluidics, neurological troubles, Alzheimer, Parkinson, organonchip, dermo-cosmetics, and toxicology

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

28 9 23 41
Fabentech Fabentech

Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields …

Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

13 4 9 45
FasTeesH FasTeesH

[Automatic translation follows] HesY, medical device for effective dental brushing in 10 seconds for healthcare and accommodation establishments 📢📢📢Our consumer product, Y-Brush, is available now: http://ow.ly/DMal30luqQK 🚀🚀🚀 FasTeesH is a Lyon startup developing a “toothbrush of the future” that cleans all teeth simultaneously, simply and effectively, in just 10 seconds. For what ? Few people like to brush their teeth. This daily task is therefore often “poorly” and/or “quickly” done. This can cause health problems, sometimes very serious. How ? Currently, we brush only 1 side of 1 tooth at a time. Our innovation allows you to brush 16 full …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

2 2 0 2
HEMARINA HEMARINA

Committed to saving lives. Hemarina is an innovative biotechnology company specializing in health product development based in Morlaix (29600, FR). Our search for new solutions based on the properties of the haemoglobin of the arenicola marina worm is permanent to improve the quality of life of patients and their families. Our commitment: to save lives by putting the patient at the heart of all our actions. BioTech, Ocean, Biomimicry, Biology, Biodiversity, and Transplantation

Type: Startup Activities: deeptech Technologies: Synthetic Biology

22 15 8 24
Medsteer Medsteer

Medsteer, with offices in Paris/France (HQ) and New York/USA, is a leading technology provider in the field of closed loop systems for the delivery of anaesthesia drugs. The company’s patented technologies focus on drug delivery solutions guided by the cortical activity of the patient. Medsteer’s proprietary closed loop anesthesia technology (“EasyTIVA”) has been successfully tested in 25 multicenter clinical trials, representing 11 000 patient inclusions, 150 anesthesiologists and 50 operating rooms in Europe since 2003. Providing full automation and customization to the individual patient’s needs, closed loop anaesthesia opens up the way to a wide array of patient benefits associated …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

0 0 0 2
Da Volterra Da Volterra

Clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiome field. Da Volterra is a clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiota field. Our mission is to discover, develop and bring to market safe and novel therapeutic options, preserving patients’ microbiota to prevent and cure life-threatening diseases. We strive to serve patients by transforming the promise of science into innovative treatments which have the power to improve health and save lives.​ Committed to innovation, Da Volterra develops products intended to protect the intestinal …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 7
PEPTINOV PEPTINOV

Peptinov is a biotechonology company based in Cochin Hospital (Paris, France) and founded by Prof. Jean-François Zagury to develop innovative peptide-based immunotherapies to treat chronic inflammatory diseases. Peptinov’s strategy is to induce the production of antibodies targeting self-proteins directly by the organism of the patient, through immunizations against carefully selected, highly immunogenic peptide sequences. Peptinov’s high potential R&D platform uses the tools of bioinformatics and molecular modelling to design these peptide sequences. This platform is potentially applicable to any crystallized protein and can quickly generate peptide candidates. Peptinov’s value proposition is built on its unique capability to develop anti-self proteins …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 1 0 15
Depixus Depixus

Depixus® is pioneering a powerful new technology based on magnetic force spectroscopy, that reveals biomolecular interactions. MAGNATM enables researchers to decode disease mechanisms and unlock a faster route to more effective therapies. Our MAGNA technology goes beyond decoding the static genetic code to reveal the dynamics of the genome that control health and disease. Single molecule analysis, RNA Drug Discovery, Protein-protein Interaction Analysis, Biophysics, Drug Discovery, Compound Screening, biomolecular interactions, and interactomics

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 1 0 63
CorWave CorWave

CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology. CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic a pulse and blood flow rates similar to those of a healthy heart. Ultimately, CorWave’s membrane pump technology is expected to reduce the complications associated with current devices and improve the management of heart failure patients. A member of the French Tech 120, CorWave was founded in 2012 by start-up …

Tags: FrenchTech120 Type: Startup Activities: deeptech healthtech manufacturing nanotech Technologies: Synthetic Biology

24 10 22 89
NEURON EXPERTS NEURON EXPERTS

Neuron Experts is a Contract Research Organization (CRO) specialized in the study of neuro-active compounds. The company uses its own tests based on primary neuronal cell cultures modeling neurodegenerative diseases. With 120m2 of independent laboratory into the North Faculty of Medicine of Marseille in France, Neuron Experts is benefiting from numerous facilities and massively invested in high-tech equipment to provide the best service to clients.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 9
CELLOMET CELLOMET

CELLOMET provides cutting-edge R&D services on cellular metabolism for needs in industry and public institutions. CELLOMET is a spin-off CRO composed of internationally recognized experts in the field of cellular metabolism. Metabolism comprises crucial biological processes which enable breakdown of sugars, proteins, and lipids necessary to provide life-sustaining energy in all types of living organisms. CELLOMET has developed in-depth knowledge and cutting-edge technologies to address any particular metabolic modification occuring at the cellular level. This expertise can be applied to study the effects of pharmacological compounds or natural extracts in cosmetology, the impact of genetic modifications or nutrition, and the …

Type: Startup Activities: biotech healthtech deeptech Technologies: Synthetic Biology

1 0 0 3
Kolibri Kolibri

Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

9 2 7 11
Carroucell Carroucell

Your CGT R&D and GMP partner. Whatever the cell you use, we have the right microcarrier for you. Tarek Fathallah, a Grenoble-based scientist and inventor, has uncovered a breakthrough in sol-gel technology with profound implications for the Healthcare industry. Driven by a passion for impactful innovation, he harnessed these properties to create tailored solutions for Cell and Gene Therapy Applications. Rooted in extensive biomanufacturing expertise, this concept addresses industry challenges by integrating cutting-edge technology into adherent cell manufacturing. Through groundbreaking research, a Microcarrier was developed, surpassing previous limitations and establishing Carroucell as a leading authority, protected by patents. In 2022, …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

2 2 0 6
RESOLUTION Spectra Systems RESOLUTION Spectra Systems

Leader in advanced optical spectroscopy with solutions dedicated to bioprocess Raman monitoring & laser characterization Leader in bioprocess analytical monitoring, RESOLUTION Spectra Systems is now part of Merck PAT, Raman spectroscopy, Chemometrics, Bioprocess, Bioprocess analytics, Cell culture monitoring, Upstream process development monitoring, Process Analytical Technology, Downstream processes control, In-line monitoring, and Real-time monitoring

Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

6 0 6 3
Luxia Scientific Luxia Scientific

New generation microbiome diagnostics for personalised medicine Luxia Scientific is a french start-up company, leading the next wave of breakthrough personalized diagnostics. The company was started by Alessandra Cervino, former research director at Enterome. Luxia scientific is pioneering the development of novel diagnostics based on the genetic analysis of microbiomes. The company has brought to the market it’s first test in Q4 2018 and is developing two additional diagnostics. The Company is affiliated to Medicen and is supported by the BPI, Region Ile de France. Statistics, Biomarkers, Statistical genetics, qPCR, genetics, genomics, microbiome, metagenomics, nutrition, well being, health, probiotics, prebiotics, …

Type: Startup Activities: biotech deeptech healthtech Technologies: Data Analytics Synthetic Biology

3 2 0 2
Fizimed Fizimed

Women's health revolution is on going | Stand up straight and move forward Fizimed is a start-up developing Emy, an innovative connected medical device to stop urinary incontinence for women through pelvic floor reeducation

Type: Startup Activities: healthtech Technologies: Synthetic Biology

18 9 5 20